Inhibitors of phosphodiesterase-4 (PDE4) are small-molecule drugs that, by increasing the
intracellular levels of cAMP in immune cells, elicit a broad spectrum of anti-inflammatory …

Severe acute respiratory syndrome-coronavirus-2 (COVID-19) virus uses Angiotensin-
Converting Enzyme 2 (ACE2) as a gateway for their entry into the human body. The ACE2 …

Objectives A major challenge for COVID-19 therapy is dysregulated immune response
associated with the disease. Umbilical cord mesenchymal stromal cells (UC-MSCs) may be …

The sharp increase in the proportion of asymptomatic cases and the potential risk of virus
transmission have greatly increased the difficulty of controlling the COVID-19 pandemic. The …

Emetine is a potent antiviral that acts on many viruses in the low-nM range, with several
studies in animals and humans demonstrating antiviral activity. Historically, emetine was …

Covid‐19 disease can involve any organ system leading to myriad manifestations and
complications. Cardiovascular manifestations are being increasingly recognised with the …

Background This systematic review and meta-analysis aimed to investigate the radiological
predictors of post-coronavirus disease 19 (COVID-19) pulmonary fibrosis and incomplete …

SARS-CoV2 infection can lead to severe cytokine storm especially in obese patients.
Ghrelin acts not only as an appetite regulator but can also play a key role in the immune …

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the novel coronavirus,
causing coronavirus disease 2019 (COVID-19). During virus infection, several pro …

Background and Objectives: An elevated procalcitonin level has classically been linked to
bacterial infections. Data on the association between elevated procalcitonin and the …